ResearcherShandong UniversityNo recent work listed
Yong Mei Tang
Matched on ORCID iD 0000-0001-5016-7667; OpenAlex author ID A5087161473. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 4
2012: 2 papers · 2013: 1 paper
Papers 3
- Correction: Knockdown of clusterin sensitizes pancreatic cancer cells to gemcitabine chemotherapy by ERK1/2 inactivation Co-author DOI 10.1186/1756-9966-32-42↗
- Knockdown of clusterin sensitizes pancreatic cancer cells to gemcitabine chemotherapy by ERK1/2 inactivation. Co-author DOI 10.1186/1756-9966-31-73↗
- Mesothelin regulates growth and apoptosis in pancreatic cancer cells through p53-dependent and -independent signal pathway. Co-author DOI 10.1186/1756-9966-31-84↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Chunning Zheng · 3 shared papers, 2012–2013 · strength 0.12
- Paper Correction: Knockdown of clusterin sensitizes pancreatic cancer cells to gemcitabine chemotherapy by ERK1/2 inactivation DOI 10.1186/1756-9966-32-42↗
- Paper Knockdown of clusterin sensitizes pancreatic cancer cells to gemcitabine chemotherapy by ERK1/2 inactivation. DOI 10.1186/1756-9966-31-73↗
- Paper Mesothelin regulates growth and apoptosis in pancreatic cancer cells through p53-dependent and -independent signal path… DOI 10.1186/1756-9966-31-84↗
- Yingsheng Jiang · 3 shared papers, 2012–2013 · strength 0.12
- Paper Correction: Knockdown of clusterin sensitizes pancreatic cancer cells to gemcitabine chemotherapy by ERK1/2 inactivation DOI 10.1186/1756-9966-32-42↗
- Paper Knockdown of clusterin sensitizes pancreatic cancer cells to gemcitabine chemotherapy by ERK1/2 inactivation. DOI 10.1186/1756-9966-31-73↗
- Paper Mesothelin regulates growth and apoptosis in pancreatic cancer cells through p53-dependent and -independent signal path… DOI 10.1186/1756-9966-31-84↗
- Fenghua Liu · 2 shared papers, 2012–2013 · strength 0.09
- Paper Correction: Knockdown of clusterin sensitizes pancreatic cancer cells to gemcitabine chemotherapy by ERK1/2 inactivation DOI 10.1186/1756-9966-32-42↗
- Paper Knockdown of clusterin sensitizes pancreatic cancer cells to gemcitabine chemotherapy by ERK1/2 inactivation. DOI 10.1186/1756-9966-31-73↗
- Shaochuan Sun · 1 shared paper, 2012 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.